Tesla, SpaceX Sue Nanotech Firm Over 'Terafab' Name

Tesla and SpaceX have filed a joint lawsuit against a nanotechnology company, accusing it of improperly using the name "Terafab," according to a report from Reuters. The filing is a notable instance of the two Elon Musk-led companies acting together in a naming or trademark-related dispute.

The Legal Filing

According to Reuters, Tesla and SpaceX allege that the nanotech firm's use of the "Terafab" name creates confusion with branding associated with the two companies. The report did not specify the exact legal claims being pursued, the jurisdiction in which the case was filed, or the remedies sought by the plaintiffs. In trademark filings of this kind, companies typically ask courts to halt continued use of a disputed name, though Reuters' summary did not confirm those specific requests in this case.

Trademark Disputes in Tech

Lawsuits over brand names are a common tool used by large corporations to protect terms they consider central to their identity, particularly when a smaller company in an adjacent industry adopts a similar-sounding name. Reuters' report did not detail whether Tesla or SpaceX has previously used the "Terafab" name in its own operations or whether the dispute instead centers on a related term already tied to either company.

Companies Behind the Suit

Tesla, primarily known for its electric vehicles and energy products, and SpaceX, the aerospace and space exploration company, are both led by Musk. Reuters did not identify the nanotech company by name in the portion of the report reviewed, nor did it include a response from the defendant. Additional details, including the precise allegations and any injunctive relief sought, were not disclosed. Tesla News Plus will provide updates as more information becomes available from Reuters or through court filings.

Source: Reuters